Cargando…
Clinical implications of germline mutations in breast cancer genes: RECQL
BACKGROUND: The identification of new hereditary breast cancer genes is an area of highly active research. In 2015, two independent studies provided initial evidence for a novel breast cancer susceptibility gene, RECQL, a DNA helicase which plays an important role in the DNA damage response. Several...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439214/ https://www.ncbi.nlm.nih.gov/pubmed/30610487 http://dx.doi.org/10.1007/s10549-018-05096-6 |